Rafael Alvarez Selected Research

Rafael Alvarez Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 08/2009
4	Weight Loss (Weight Reduction) 01/2023 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2017
2	Gastroesophageal Reflux (GERD) 01/2023 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 05/2017
2	Adenocarcinoma 01/2018 - 12/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 07/2009
2	Venous Thromboembolism 04/2015 - 05/2014
2	Alzheimer Disease (Alzheimer's Disease) 02/2015 - 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2023
1	Proteinuria 08/2023
1	Inflammation (Inflammations) 08/2023
1	Hypertrophy 08/2023
1	Chronic Renal Insufficiency 08/2023
1	Atherosclerosis 08/2023
1	Hypoxia (Hypoxemia) 01/2021
1	Urticaria (Hives) 12/2020
1	Hypersensitivity (Allergy) 12/2020
1	Insulin Resistance 02/2020
1	Obesity 02/2020
1	Edema (Dropsy) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Leukocytosis (Pleocytosis) 01/2020
1	Disease Progression 01/2020
1	Morbid Obesity 12/2019
1	Breast Neoplasms (Breast Cancer) 11/2018
1	Femoral Neck Fractures 05/2018
1	Adult Form Polyglucosan Body Disease 01/2018
1	Late Onset Disorders 01/2018
1	Clinical Deterioration 05/2017
1	Lung Neoplasms (Lung Cancer) 08/2015
1	Pneumonia (Pneumonitis) 05/2014
1	Blindness (Hysterical Blindness) 02/2002
1	Acidosis 02/2002
1	Poisoning 02/2002

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
3	LipidsIBA 01/2021 - 08/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2017
2	PlatinumIBA 01/2021 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 02/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 05/2017 - 08/2009
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2015 - 08/2009
1	CreatinineIBA 08/2023
1	Enalapril FDA LinkGeneric 08/2023
1	LDL CholesterolIBA 08/2023
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2023
1	Apolipoproteins E (ApoE)IBA 08/2023
1	Docosahexaenoic AcidsIBA 01/2021
1	docosapentaenoic acidIBA 01/2021
1	prostaglandin E3 (PGE3)IBA 01/2021
1	AcidsIBA 01/2021
1	CalciumIBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2021
1	AllergensIBA 12/2020
1	Insulin (Novolin)FDA Link 02/2020
1	salicylhydroxamic acid (SHAM)IBA 02/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	ElectrolytesIBA 01/2020
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	vanucizumabIBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2020
1	Hormones (Hormone)IBA 11/2018
1	1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA 01/2018
1	GuaiacolIBA 01/2018
1	polyglucosanIBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 12/2017
1	Gemcitabine FDA Link 12/2017
1	Cetuximab (Erbitux)FDA Link 05/2017
1	Cell-Free Nucleic AcidsIBA 05/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	TrioleinIBA 08/2015
1	Triglycerides (Triacylglycerol)IBA 08/2015
1	Olive OilIBA 08/2015
1	Protein Kinases (Protein Kinase)IBA 08/2015
1	Mitogen-Activated Protein Kinase 3IBA 08/2015
1	hydroxytrioleinIBA 08/2015
1	AlkaloidsIBA 02/2015
1	AcetylcholinesteraseIBA 01/2015
1	4-hexyloxyaniline (HOA)IBA 08/2009
1	Methanol (Carbinol)IBA 02/2002

Therapy/Procedure

5	Therapeutics 08/2023 - 05/2017
5	Bariatric Surgery 01/2023 - 12/2019
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
4	Gastrectomy 01/2023 - 01/2020
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023 - 01/2020
1	Osteotomy 05/2018
1	Neoadjuvant Therapy 12/2017
1	Early Ambulation 04/2015
1	Chemoprevention 05/2014
1	Critical Care (Surgical Intensive Care) 05/2014
1	Adjuvant Chemotherapy 07/2009
1	Renal Dialysis (Hemodialysis) 02/2002